Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 2, 2008 - Issue 3
Submit an article Journal homepage
42
Views
6
CrossRef citations to date
0
Altmetric
Review

Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Bernard Escudier1 Unité Immunothérapie, Institut Gustave Roussy, Villejuif, FranceCorrespondence[email protected]
,
Jan Cosaert2 F. Hoffmann-La Roche Ltd, Basel, Switzerland
&
Sangeeta Jethwa2 F. Hoffmann-La Roche Ltd, Basel, Switzerland
Pages 517-530 | Published online: 12 Sep 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mathilde Lafon, Charlotte Domblides, Amaury Daste, Baptiste Sionneau, Alain Ravaud, Jean-Christophe Bernhard & Marine Gross-Goupil. (2020) Atezolizumab for the treatment of renal cell carcinoma. Expert Opinion on Biological Therapy 20:7, pages 679-686.
Read now
Alice Guazzelli, Emyr Bakker, Kun Tian, Constantinos Demonacos, Marija Krstic-Demonacos & Luciano Mutti. (2017) Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma. Expert Opinion on Investigational Drugs 26:8, pages 933-944.
Read now
Emyr Bakker, Alice Guazzelli, Marija Krstic-Demonacos, Michael Lisanti, Federica Sotgia & Luciano Mutti. (2017) Current and prospective pharmacotherapies for the treatment of pleural mesothelioma. Expert Opinion on Orphan Drugs 5:6, pages 455-465.
Read now

Articles from other publishers (3)

Dorcas Akuba-Muhyia Annan, Hiroshi Kikuchi, Nako Maishi, Yasuhiro Hida & Kyoko Hida. (2020) Tumor Endothelial Cell—A Biological Tool for Translational Cancer Research. International Journal of Molecular Sciences 21:9, pages 3238.
Crossref
A. Narayana, S. Kunnakkat, J. Chacko-Mathew, S. Gardner, M. Karajannis, S. Raza, J. Wisoff, H. Weiner, D. Harter & J. Allen. (2010) Bevacizumab in recurrent high-grade pediatric gliomas. Neuro-Oncology 12:9, pages 985-990.
Crossref
Camillo Porta & Cezary Szczylik. (2009) Tolerability of first-line therapy for metastatic renal cell carcinoma. Cancer Treatment Reviews 35:3, pages 297-307.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.